AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
PHASE I-II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND 5-FLUOROURACIL(5-FU) IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Authors: SCHRIJVERS D VANHERPEN C KERGER J JOOSENS E BRANDELY M VERMORKEN JB
Citation: D. Schrijvers et al., PHASE I-II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND 5-FLUOROURACIL(5-FU) IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), Annals of oncology, 9, 1998, pp. 359-359
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D REIFFERS J ATTAL M STOPPA AM MARIT G HUGUET F MOLINA L PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 78 PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AL)IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Bone marrow transplantation, 21, 1998, pp. 368-368
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAI M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, British Journal of Haematology, 102(1), 1998, pp. 89-89
CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: VEY N VIENS P FOSSAT C OLIVE D SAINTY D BAUME D STOPPA AM BOUABDALLAH R BRANDELY M GASTAUT JA MARANINCHI D BLAISE D
Citation: N. Vey et al., CLINICAL AND BIOLOGICAL EFFECTS OF GAMMA-INTERFERON AND THE COMBINATION OF GAMMA-INTERFERON AND INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, European cytokine network, 8(4), 1997, pp. 389-394
THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELLEC G VERNANT JP LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., THE USE OF A SEQUENTIAL HIGH-DOSE RECOMBINANT INTERLEUKIN-2 REGIMEN AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION DOES NOT IMPROVE THE DISEASE-FREE SURVIVAL OF PATIENTS WITH ACUTE-LEUKEMIA TRANSPLANTED IN FIRSTCOMPLETE REMISSION, Leukemia & lymphoma, 25(5-6), 1997, pp. 469-478
TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS
Authors: VEY N BLAISE D OLIVE D LAFAGE M VIENS P BAUME D CAMERLO J STOPPA AM GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: N. Vey et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 - RESULTS OF A PHASE-II STUDY IN 21 PATIENTS, Experimental hematology, 25(8), 1997, pp. 481-481
RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP
Authors: BLAISE D ATTAL M REIFFERS J STOPPA AM HUGUET F MARIT G MOLINA L BELLANGER C PICO JL GABUS R BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., RANDOMIZED STUDY OF INTERLEUKIN-2 (RIL2) AFTER AUTOLOGOUS BONE-MARROWTRANSPLANTATION (BMT) IN 130 PATIENTS WITH ACUTE-LEUKEMIA (AL) IN FIRST COMPLETE REMISSION (CR-1) - RESULTS OF A MULTICENTRIC TRIAL WITH A 5-YEAR FOLLOW-UP, Blood, 90(10), 1997, pp. 491-491
A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMAS
Authors: VEY N BLAISE D TIBERGHIEN P ATTAL M PICO JL REIFFERS J HARROUSSEAU JL FIERE D TABILIO A GABUS R BRANDELY M MARANINCHI D
Citation: N. Vey et al., A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN MALIGNANT-LYMPHOMAS, Leukemia & lymphoma, 21(1-2), 1996, pp. 107-114
INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY
Authors: PUJADELAURAINE E GUASTALLA JP COLOMBO N DEVILLIER P FRANCOIS E FUMOLEAU P MONNIER A NOOY M MIGNOT L BUGAT R MARQUES C MOUSSEAU M NETTER G MALOISEL F LARBAOUI S BRANDELY M
Citation: E. Pujadelauraine et al., INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Journal of clinical oncology, 14(2), 1996, pp. 343-350
A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1
Authors: BLAISE D ATTAL M REIFFERS J MOLINA L BELLANGER C PICO JL NEDELEC G VERNANT JP TROUSSARD X LEGROS M GISSELBRECHT C ROSSI JF BRANDELY M HERCEND T MARANINCHI D
Citation: D. Blaise et al., A PROSPECTIVE RANDOMIZED STUDY OF R-IL2 AFTER AUTOLOGUOUS BMT FOR ACUTE-LEUKEMIA IN CR-1, Experimental hematology, 24(9), 1996, pp. 368-368
A PILOT-STUDY OF GAMMA-INTERFERON WITH OR WITHOUT INTERLEUKIN-2 AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MALIGNANCIES
Authors: VEY N MARANINCHI D OLIVE D FOSSAT C BAUME D SAINTY D STOPPA AM VIENS P BRANDELY M BLAISE D
Citation: N. Vey et al., A PILOT-STUDY OF GAMMA-INTERFERON WITH OR WITHOUT INTERLEUKIN-2 AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MALIGNANCIES, Experimental hematology, 24(9), 1996, pp. 369-369
NONCYTOTOXIC CD4 TUMOR-INFILTRATING LYMPHOCYTES INDUCE RESPONSES IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA PREVIOUSLY TREATED WITH INTERLEUKIN-2
Authors: MATHIOT C THIOUNN N TARTOUR E FLAM T PEYRET C JOYEUX I ZERBIB M BRANDELY M DEBRE B FRIDMAN WH
Citation: C. Mathiot et al., NONCYTOTOXIC CD4 TUMOR-INFILTRATING LYMPHOCYTES INDUCE RESPONSES IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA PREVIOUSLY TREATED WITH INTERLEUKIN-2, European journal of cancer, 31A(9), 1995, pp. 1551-1552
PHASE I-II STUDY OF INTERLEUKIN-2 AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POORLY RESPONDING NEUROBLASTOMA
Authors: VALTEAUCOUANET D RUBIE H MERESSE V FARACE F BRANDELY M HARTMANN O
Citation: D. Valteaucouanet et al., PHASE I-II STUDY OF INTERLEUKIN-2 AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POORLY RESPONDING NEUROBLASTOMA, Bone marrow transplantation, 16(4), 1995, pp. 515-520
INDUCTION OF CUTANEOUS GRAFT-VERSUS-HOST LIKE REACTION BY RECOMBINANTIL-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: COSTELLO R BLAISE D JACQUEMIER J MONGES G STOPPA AM VIENS P OLIVE D BOUABDALLAH R BRANDELY M GASTAUT JA MARANINCHI D
Citation: R. Costello et al., INDUCTION OF CUTANEOUS GRAFT-VERSUS-HOST LIKE REACTION BY RECOMBINANTIL-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(1), 1995, pp. 199-200
SUCCESSFUL ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION OF 1O-DAY CULTURED BONE-MARROW ACTIVATED BY INTERLEUKIN-2 IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: BEAUJEAN F BERNAUDIN F KUENTZ M LEMERLE S CORDONNIER C LEFORESTIER C REINERT P DUEDARI N BRANDELY M VERNANT JP
Citation: F. Beaujean et al., SUCCESSFUL ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION OF 1O-DAY CULTURED BONE-MARROW ACTIVATED BY INTERLEUKIN-2 IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Bone marrow transplantation, 15(5), 1995, pp. 691-696
LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION
Authors: BLAISE D ATTAL M PICO JL REIFFERS J STOPPA AM BELLANGER C MOLINA L NEDELEC G VERNANT JM LEGROS M GABUS R HUGUET F BRANDELY M HERCEND T OLIVE D MARANINCHI D
Citation: D. Blaise et al., LEUKEMIA-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY INTERLEUKIN-2 IN 50 PATIENTS WITH ACUTE-LEUKEMIA IN FIRST REMISSION, Blood, 86(10), 1995, pp. 364-364
TREATMENT WITH LOW-DOSE IL-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML)
Authors: FALKENBURG JHF SCHAAFSMA MR SMITH WM KLUINNELEMANS JC HOOFTMANDENOTTER A RIJNBEEK M VANDEMAREL A SCHELLEKENS M BRANDELY M FIBBE WE WILLEMZE R
Citation: Jhf. Falkenburg et al., TREATMENT WITH LOW-DOSE IL-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 2252-2252
A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN 25 MALIGNANT-LYMPHOMAS
Authors: VEY N BLAISE D TIBERGHIEN P ATTAL M PICO JL REIFFERS J HARROUSSEAU JL FIERE D TABILIO A GABUS R BRANDELY M STOPPA AM MARANINCHI D
Citation: N. Vey et al., A PILOT-STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWED BY RECOMBINANT INTERLEUKIN-2 IN 25 MALIGNANT-LYMPHOMAS, Blood, 86(10), 1995, pp. 3874-3874
HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CUTANEOUS T-CELL LYMPHOMA
Authors: MAROLLEAU JP BACCARD M FLAGEUL B RYBOJAD M LAROCHE L VEROLA O BRANDELY M MOREL P GISSELBRECHT C
Citation: Jp. Marolleau et al., HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED CUTANEOUS T-CELL LYMPHOMA, Archives of dermatology, 131(5), 1995, pp. 574-579
MODIFICATIONS OF LEUKEMIC BLAST CELLS INDUCED BY IN-VIVO HIGH-DOSE RECOMBINANT INTERLEUKIN-2
Authors: OLIVE D CHAMBOST H SAINTY D STOPPA AM BLAISE D ELMARSAFY S BRANDELY M MANNONI P MAWAS C MARANINCHI D
Citation: D. Olive et al., MODIFICATIONS OF LEUKEMIC BLAST CELLS INDUCED BY IN-VIVO HIGH-DOSE RECOMBINANT INTERLEUKIN-2, Leukemia, 8(7), 1994, pp. 1230-1235
INCREASED EXPRESSION OF PERFORIN AND GRANZYME-B GENES IN PATIENTS WITH METASTATIC MELANOMA TREATED WITH RECOMBINANT INTERLEUKIN-2
Authors: LEGERRAVET MB MATHIOT C PORTIER A BRANDELY M GALANAUD P FRIDMAN WH EMILIE D
Citation: Mb. Legerravet et al., INCREASED EXPRESSION OF PERFORIN AND GRANZYME-B GENES IN PATIENTS WITH METASTATIC MELANOMA TREATED WITH RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(1), 1994, pp. 53-58
PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES FROM PATIENTS WITH RENAL-CELL CARCINOMA
Authors: THIOUNN N MATHIOT C TARTOUR E JOYEUX I PEYRET C BRANDELY M DESLIGNIERES S DEBRE B FRIDMAN WH
Citation: N. Thiounn et al., PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES FROM PATIENTS WITH RENAL-CELL CARCINOMA, European urology, 25(2), 1994, pp. 151-157
INTERLEUKIN-2 TREATMENT IN LYMPHOMA - A PHASE-II MULTICENTER STUDY
Authors: GISSELBRECHT C MARANINCHI D PICO JL MILPIED N COIFFIER B DIVINE M TIBERGHIEN P BOSLY A TILLY H BOULAT O BRANDELY M
Citation: C. Gisselbrecht et al., INTERLEUKIN-2 TREATMENT IN LYMPHOMA - A PHASE-II MULTICENTER STUDY, Blood, 83(8), 1994, pp. 2081-2085
IMMUNOTHERAPY WITH RECOMBINANT IL2 (RIL2) IN THE TREATMENT OF MALIGNANT LYMPHOMAS-(L)
Authors: BLAISE D GISSELBRECHT C VEY N PICO JL TIBERGHIEN P MILPIED N COIFFIER B ATTAL M BOSLY A REIFFERS J TILLY H TABILIO A GABUS R BRANDELY M MARANINCHI D
Citation: D. Blaise et al., IMMUNOTHERAPY WITH RECOMBINANT IL2 (RIL2) IN THE TREATMENT OF MALIGNANT LYMPHOMAS-(L), Journal of cellular biochemistry, 1993, pp. 268-268
AUTO BMT FOLLOWED BY RECOMBINANT IL2 (RIL2) IN 41 PATIENTS WITH CR-1 ACUTE-LEUKEMIA
Authors: BLAISE D STOPPA AM OLIVE D ATTAL M PICO JL BELLANGER C REIFFERS J LEGROS M MICHALLET M GABUS R BRANDELY M MARANINCHI D
Citation: D. Blaise et al., AUTO BMT FOLLOWED BY RECOMBINANT IL2 (RIL2) IN 41 PATIENTS WITH CR-1 ACUTE-LEUKEMIA, Experimental hematology, 21(8), 1993, pp. 1115-1115
Risultati: 1-25 | 26-30